OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
Erika Stucchi, Michela Bartolini, Marco Airoldi, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 371-382
Open Access | Times Cited: 7
Erika Stucchi, Michela Bartolini, Marco Airoldi, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 371-382
Open Access | Times Cited: 7
Showing 7 citing articles:
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
Carmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Carmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Efficacy and safety of fruquintinib plus capecitabine as first-line treatment in patients with metastatic colorectal cancer ineligible for intravenous chemotherapy: a two-stage, single-armed, phase II study
Xin Wang, Zhigang Bai, Wei Deng, et al.
Investigational New Drugs (2025)
Closed Access
Xin Wang, Zhigang Bai, Wei Deng, et al.
Investigational New Drugs (2025)
Closed Access
Polypharmacology: new drugs in 2023–2024
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access
Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 3
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 3
Clinical research progress of fruquintinib in the treatment of malignant tumors
Shihao Zhao, Wenhui Wang, Jingyi Li, et al.
Investigational New Drugs (2024)
Open Access | Times Cited: 1
Shihao Zhao, Wenhui Wang, Jingyi Li, et al.
Investigational New Drugs (2024)
Open Access | Times Cited: 1
Profile of Fruquintinib in the Management of Advanced Refractory Metastatic Colorectal Cancer: Design, Development and Potential Place in Therapy
Sebawe Syaj, Anwaar Saeed
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5203-5210
Open Access
Sebawe Syaj, Anwaar Saeed
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5203-5210
Open Access
Evaluation of fruquintinib’s efficacy and safety in refractory metastatic colorectal cancer: a systematic review and meta-analysis of phase II and III randomized controlled trials
Eric Ricardo Yonatan, Rivaldi Ruby, Alver Prasetya, et al.
Clinical Journal of Gastroenterology (2024) Vol. 18, Iss. 1, pp. 11-22
Closed Access
Eric Ricardo Yonatan, Rivaldi Ruby, Alver Prasetya, et al.
Clinical Journal of Gastroenterology (2024) Vol. 18, Iss. 1, pp. 11-22
Closed Access
